Ballew Advisors, Inc Merck & Co., Inc. Transaction History
Ballew Advisors, Inc
- $142 Million
- Q1 2024
A detailed history of Ballew Advisors, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ballew Advisors, Inc holds 3,035 shares of MRK stock, worth $386,355. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,035
Previous 3,021
0.46%
Holding current value
$386,355
Previous $329,000
21.58%
% of portfolio
0.28%
Previous 0.25%
Shares
12 transactions
Others Institutions Holding MRK
# of Institutions
3,771Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$31 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.4 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.9 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$11 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.18 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $322B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...